Staged autologous peripheral blood progenitor cell transplantation for Ewing sarcoma and rhabdomyosarcoma

Internal Medicine Journal

Volumn 34, Issue 7, 2004, Pages 431-434

  Ritchie, D S ^a   Grigg, A P ^a   Roberts, A W ^a   Rosenthal, M A ^a   Fox, R M ^a   Szer, J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CARBOPLATIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUCONAZOLE; IFOSFAMIDE; MESNA; NARCOTIC ANALGESIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; EWING SARCOMA; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MUCOSA INFLAMMATION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SEPSIS; STEM CELL MOBILIZATION; TECHNIQUE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RHABDOMYOSARCOMA; RISK ASSESSMENT; SARCOMA, EWING'S; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VICTORIA;

EID: 4143057964     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2004.00630.x     Document Type: Article

References (21)

1. Grier HE. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 1997; 44: 991-1004.
2. Anderson J, Gordon A, Pritchard-Jones K, Shipley J. Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer 1999; 26: 275-85.
3. Cangir A, Vietti TJ, Gehan EA, Burgert EO Jr,, Thomas P, Tefft M et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990; 66: 887-93.
4. Gururangan S, Marina NM, Luo X, Parham DM, Tzen CY, Greenwald CA et al. Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy. J Pediatr Hematol Oncol 1998; 20: 55-61.
5. Wexler LH, DeLaney TF, Tsokos M, Avila N, Steinberg SM, Weaver-McClure L et al. Ifosfamide and etoposide plus vincristine, doxorubicin and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer 1996; 78: 901-11.
6. Marina NM, Pappo AS, Parham DM, Cain AM, Rao BN, Poquette CA et al. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St Jude Children's Research Hospital. J Clin Oncol 1999; 17: 180-90.
7. Eralp Y, Bavbek S, Basaran M, Kaytan E, Yaman F, Bilgic B et al. Prognostic factors and survival in late adolescent and adult patients with small round cell tumors. Am J Clin Oncol 2002; 25: 418-24.
8. Kushner BH, Meyers PA. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol 2001; 19: 870-80.
9. Paulussen M, Ahrens S, Burdach S, Dunst J, Frohlich B, Jabar S et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. Ann Oncol 1998; 9: 275-81.
10. Ladenstein R, Lasset C, Pinkerton R, Zucker JM, Peters C, Burdach S et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 1995; 15: 697-705.
11. Horowitz ME, Kinsella TJ, Wexler LH, Belasco J, Triche T, Tsokos M et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma; J Clin Oncol 1993; 11: 1911-8.
12. Boulad F, Kernan NA, LaQuaglia MP, Heller G, Lindsley KL, Rosenfield NS et al. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. J Clin Oncol 1998; 16: 1697-706.
13. Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001; 19: 2812-20.
14. Perentesis JP, Katsanis E, DeFor TE, Neglia J, Ramsay N. Autologous stem cell transplantation for high-risk pediatric solid tumors. Bone Marrow Transplant 1999; 24: 609-15.
15. Ozkaynak MF, Matthay K, Cairo M, Harris RE, Feig S, Reynolds CP et al. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors. J Clin Oncol 1998; 16: 937-44.
16. Bertuzzi A, Castagna L, Nozza A, Quagliuolo V, Siracusano L, Balzarotti M et al. High-dose chemotherapy in poor-prognosis adult small round-cell tumors: Clinical and molecular results from a prospective study. J Clin Oncol 2002; 20: 2181-8.
17. Burdach S, Meyer-Bahlburg A, Laws HJ, Haase R, van Kaik B, Metzner B et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol 2003; 15: 3072-8.
18. Walterhouse DO, Hoover ML, Marymont MA, Kletzel M. High-dose chemotherapy followed by peripheral blood stem cell rescue for metastatic rhabdomyosarcoma: the experience at Chicago Children's Memorial Hospital. Med Pediatr Oncol 1999; 32: 88-92.
19. Miser J, Krailo M, Smith M, Rubinstein L, Meyers P, Rausen A et al. Secondary leukemia (SL) or myelodysplastic syndrome (MDS) following therapy for Ewing's sarcoma (ES). Proc Am Soc Clin Oncol 1997; 16: 518a.
20. Basser RL, To LB, Collins JP, Begley CG, Keefe D, Cebon J et al. Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-up. J Clin Oncol 1999; 17: 82-92.
21. Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7: 1748-56.